Company profile: Truvic Medical
1.1 - Company Overview
Company description
- Provider of devices for single-session thrombus removal without thrombolytics, including Symphony, a device that uses continuous aspiration and mechanical assistance to engage and disrupt clots, and Prodigy.
Products and services
- Single-Session Thrombus Removal: Delivers clot removal completed in one procedure without thrombolytics, enabling extraction of thrombus in a single session, clinical-grade
- Symphony Product: Device engineers thrombus removal via continuous aspiration with mechanical assistance to engage and disrupt clots for single-session extraction without thrombolytics, medical-grade
- Prodigy Product: Referenced product with no detailed description, likely related to thrombus removal or vascular intervention within Truvic’s portfolio, custom-engineered
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Truvic Medical
Nanostim
HQ: United States
Website
- Description: Provider of early-stage medical device technology aimed at preventing complications related to pacemakers, addressing more than 100,000 annual incidents. The company has assembled a world-class team of experienced medical device engineers to bring this technology to market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanostim company profile →
Bivacor
HQ: United States
Website
- Description: Provider of centrifugal heart pumps, including the BiVACOR Total Artificial Heart, a long-term rotary blood pump device with magnetic levitation for patients with severe heart failure. Offers magnetic levitation to reduce mechanical wear, smart controllers that adapt pump operation to patient activity, and a portable external controller and batteries to enable mobility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bivacor company profile →
On-X Life Technologies
HQ: United States
Website
- Description: Provider of mechanical heart valve replacement and cardiac surgery products, developing, manufacturing, and offering artificial heart valve replacement and repair solutions. Portfolio includes On-X Prosthetic Heart Valve; aortic valves with Standard, Conform-X, and Anatomic sewing rings; mitral valves with Standard sewing ring; On-X Ascending Aortic Prosthesis; Chord-X ePTFE sutures, pre-measured loops and adjustable suture system; Chord-X Chordal Sizer; CarbonAid and CarbonMini.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full On-X Life Technologies company profile →
Cardionics
HQ: United States
Website
- Description: Provider of auscultation simulation products and services that support classroom education, clinical and telehealth programs in medical institutions and universities worldwide, including the SAM4 Auscultation Manikin, electronic stethoscopes (options for hearing-impaired users), Bionic Hybrid Simulator, SAM Online remote training, and telehealth systems for sharing live physiological sounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardionics company profile →
Marea Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapies leveraging human genetics to develop next-generation treatments for cardiometabolic diseases. Pipeline includes MAR001, a monoclonal antibody targeting ANGPTL4 to reduce remnant cholesterol and triglycerides and improve adipose tissue function (Phase 2), MAR002, an anti-growth hormone receptor antibody for acromegaly, and undisclosed discovery programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marea Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Truvic Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Truvic Medical
2.2 - Growth funds investing in similar companies to Truvic Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Truvic Medical
4.2 - Public trading comparable groups for Truvic Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →